Wockhardt informs about press release

28 Jul 2025 Evaluate

Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed Press Release ‘Leading U.K. Medical Journal publishes a Complex Case of Severe Pan-drug Resistant Infection in U.S. Liver Transplant Patient Successfully Treated with Zaynich® (Zidebactam/Cefepime, WCK 5222)’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1395.90 47.70 (3.54%)
09-Apr-2026 12:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.50
Dr. Reddys Lab 1211.35
Cipla 1227.00
Zydus Lifesciences 904.60
Lupin 2297.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×